• AS Severity Conflict; Non-Implant LAA Closure; Who Forgoes Thrombectomy?

    Interventional cardiology news to note

    Why might CT and echocardiographic Doppler parameters produce different assessments of aortic stenosis (AS) severity? Computational fluid dynamics point to high flow as the main culprit for the inconsistency. (Open Heart)

    For patients with prior coronary artery bypass graft (CABG) surgery presenting with non-ST elevation acute coronary syndromes, outcomes did not appear dramatically different between those randomized to medical management and those assigned to invasive management, a small trial showed. (Circulation: Cardiovascular Interventions).

    When treating left main disease in patients with cardiogenic shock, neither a two-stent strategy nor use of an intra-aortic balloon pump helped outcomes after percutaneous coronary intervention, according to a report in Catheterization and Cardiovascular Interventions.

    Operators in the U.K. reported a positive initial clinical experience with Medtronic's novel quadripolar active fixation left ventricular lead, the Attain Stability Quad 2798, for cardiac resynchronization therapy. The lead underwent a limited release there 2 years ago and has been FDA approved since May of this year. (JACC: Clinical Electrophysiology)

    First-in-human procedures have been successful with Lariat with EpiRail, an epicardial-only, left atrial appendage (LAA) closure device that delivers a pre-tied suture loop to the LAA while leaving behind no metal or other implant material. This approach is under investigation in the aMAZE trial in the U.S.

    Socioeconomic disparities persist in the use of mechanical thrombectomy even after its entrance into the mainstream, according to a study in Stroke. Hospitals with lower utilization rates tended to have more female patients, patients with Medicaid or no insurance at all, or more black and Hispanic patients.

    The SeQuent Please ReX drug-coated balloon got Breakthrough Device Designation from the FDA for the treatment of coronary in-stent restenosis, B. Braun announced. This gives it a quicker review process for approval.


    Read the original article on Medpage Today: AS Severity Conflict; Non-Implant LAA Closure; Who Forgoes Thrombectomy?

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details